Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in Vitro

Cancer Letters

Volumn 99, Issue 2, 1996, Pages 239-245

  McCotter, D ^a   Van Den Berg, H W ^a   Boylan, M ^a   McKibben, B ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast cancer; Insulin like growth factor binding protein; Insulin like growth factor I; Receptors; Tamoxifen resistance

Indexed keywords

ESTROGEN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 0030067040     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04104-4     Document Type: Article

References (22)

1. Kryicki, R.F. and Yee, D. (1992) The insulin-like growth factor family of ligands, receptors and binding proteins. Breast Cancer Res. Treat., 22, 7-19.
2. Sara, V.R. and Hall, K. (1990) Insulin-like growth factors and their binding proteins. Physiol. Rev., 70, 591-614.
3. Pekonen, F., Nyman, T., Ilvesmaki, V. and Partanen, S. (1992) Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res., 52, 5204-5207.
4. De Leon, D.D., Wilson, D.M., Bakker, B., Lamson, G., Hintz, R.L. and Rosenfeld, R.G. (1989) Characterisation of insulin-like growth factor binding proteins from human breast cancer cells. Mol. Endocrinol., 3, 567-574.
5. Yee, D., Favoni, R.E., Lippman, M.E. and Powell, D.R. (1991) Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res. Treat., 18, 3-10.
6. Zapf, J., Schoenle, E., Jagars, G., Sand, I., Grunwald, J. and Froesch, E. R. (1979) Inhibition of the action of non-suppressible insulin-like activity (NSILA-S) on isolated rat fat cells by binding to its carrier protein. Clin. Invest., 63, 1077-1084.
7. De Mellow, J.S. and Baxter, R.C. (1988) Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun., 156, 199-204.
8. Figueroa, J.A., Sharma, J., Jackson, J.G., McDermott, M.J., Hilsenbeck, S.G. and Yee, D. (1993) Recombinant insulin-like growth factor (IGF) binding protein I inhibits IGF-I, serum and estrogen-dependent growth of MCF-7 human breast cancer cells. Cell. Physiol., 157, 229-236.
9. Pratt, S.E. and Pollak, M.N. (1994) Insulin-like growth factor binding protein 3 inhibits estrogen-stimulated breast cancer cell proliferation. Biochem. Biophys. Res. Commun., 198, 292-297.
10. Jones, J.I., D'Ercole, A.J., Camacho-Hubner, C. and Clemmons, D.R. (1991) Phosphorylation of insulin-like growth factor (IGF)-binding protein I in cell culture and in vivo: effects of affinity for IGF-I. Proc. Natl. Acad. Sci. USA, 88, 7481-7485.
11. Clemmons, D.R., Camacho-Hubner, C., Coronado, E. and Osborne, C.K. (1990) Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology, 127, 2679-2686.
12. Pratt, S.E. and Pollak, M.N. (1993) Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell prolif7 eration is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res., 53, 5193-5198.
13. van den Berg, H.W., Boyland, M., Long B. and Lynch, M. (1994) Sensitivity of human breast cancer cells to suramin in relation to expression of epidermal growth factor receptors. Proc. Am. Assoc. Cancer Res., 35, 259, A1547.
14. Long, B., McKibben, B., Lynch, M. and van den Berg, H.W. (1992) Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. Br. J. Cancer, 65, 865-869.
15. Bronzert, D.A., Greene, G.L. and Lippman, M.E. (1985) Selection and characterisation of a breast cancer cell line resistant to the antiestrogen LY 117018. J. Endocrinol., 117, 1409-1417.
16. van den Berg, H.W., Lynch, M., Martin, J.H.J., Nelson, J., Dickson, G.R. and Crockard, A.D. (1989) Characterisation of a tamoxifen resistant variant of the ZR-75-1 human breast cancer cell line, ZR-75-9a1 and stability of the resistant phenotype. Br. J Cancer, 59, 522-526.
17. van den Berg, H.W., Martin, J. and Lynch, M. (1990) High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. Br. J. Cancer, 61, 504-507.
18. Fraker, P.J. and Speck, J.C. (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6b-diphenlglycouril. Biochem. Biophys. Res. Commun., 80, 849-857.
19. Keightly, D.D. and Cressie, N.A.C. (1980) The Woolf plot is more reliable than the Scatchard plot in analysing data from hormone receptor assays. J. Steroid. Biochem., 13, 1317-1323.
20. Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76, 4350-4354.
21. Martin, J.L. and Baxter, R.C. (1986) Insulin-like growth factor-binding proteins from human plasma. Purification and characterisation. J. Biol. Chem., 261, 8754-8760.
22. Shimaski, S. and Ling, N. (1991) Identification and molecular characterisation of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res., 3, 243-266.